A few years ago, with the legalization of cannabis in Canada and other countries, chemists rushed to isolate active compounds from the plant, synthesize new cannabinoid derivatives and formulate new preparations for the delivery of these active compounds
Articles
New nonprofit aims to advise on creation of Oregon’s psilocybin-assisted therapy system
The people who brought psilocybin-assisted therapy to Oregon have created a new nonprofit to make sure the spirit of the ballot measure is preserved as state officials turn the voter-approved initiative into official policy.
Self-admitted psychedelic use and association with psychedelic culture harm perceptions of researchers’ scientific integrity
Psychedelic researchers who admit to using the substances themselves tend to be viewed as having less integrity compared to their abstinent counterparts, according to new research that surveyed 952 individuals from the United States.
ATAI IPO Strategy: Load Up On OTHER Stocks First
ATAI Life Sciences is set to become the new industry leader among psychedelic stocks. But it may not be the best OPPORTUNITY for investors when trading begins.
Hemp And CBD Could Be Marketed As Dietary Supplements Under Bipartisan Congressional Bill
A bipartisan group of lawmakers reintroduced a bill in Congress on Thursday that would allow hemp and CBD derived from the crop to be marketed and sold as dietary supplements.
Mindset Files Multiple Final Patent Applications on Its Novel Psilocybin-Inspired Compounds
Mindset has filed multiple patent applications regarding "both novel prodrug and deuterated derivatives of psilocybin".
Tryp Therapeutics Announces Strategic Investment of $2,000,000
Tryp Therapeutics announces a CAD$2.0 private placement at a unit price of CAD$0.60
New Jersey Governor Signs Psilocybin Bill To Immediately Reduce Penalties For Possession
New Jersey Gov. Phil Murphy (D) signed a psilocybin reform bill into law on Thursday, immediately reclassifying possession of up to an ounce of psychedelic-containing mushrooms as a disorderly persons offense.
Cybin Announces Closing of Upsized Bought Deal Offering
Cybin has closed on a CAD$34 million bought deal financing. Has raised nearly CAD$90 million to date.
Should psychedelic drugs be decriminalized in Mass.? Advocates see opening
Somerville in January became the first jurisdiction in Massachusetts to move toward decriminalizing plant-based psychedelic drugs, with city leaders voting unanimously to recognize the medical uses of natural entheogens — including psilocybin, the active ingredient in “magic mushrooms” — and make them among the lowest enforcement priorities for local police.
Cambridge City Council Decriminalizes Psychedelics And Urges Police To End Drug Arrests More Broadly
Cambridge, Massachusetts has become the latest city to decriminalize a wide range of psychedelics following a City Council vote on Wednesday.
The Road To Psychedelics Legalization, Part 2: Psilocybin and MDMA
Psilocybin and MDMA stand out as the two psychedelic drugs with the shortest paths to legalization.
Florida Lawmaker Wants to Legalize Psychedelic Mushrooms by 2022
Although Florida has a history of being slow on the draw when it comes to legalizing drug use (see: the failed effort to legalize recreational marijuana), a Florida lawmaker is hoping the state will take the leap into psychedelics and legalize medical mushrooms as early as 2022.
Pot stocks boom as industry sees prohibition ending
GameStop and the "meme" stocks have attracted much of the market's attention in recent weeks, but cannabis stocks have been the market's real standout in 2021 thanks to renewed expectations of U.S. legalization.
Virginia Marijuana Legalization Bills Cleared For Full Senate And House Votes This Week
Bills to legalize marijuana in Virginia advanced out of two committees on Wednesday, the final step before full floor action.